FDA has classified its recent recall of Edwards Lifesciences’ (NYSE:EW) Sapien 3 Ultra delivery system as Class I due to health risks associated with its use. However, the products will remain in the ...
NYON, Switzerland--(BUSINESS WIRE)--Edwards Lifesciences today announced the launch in Europe of the SAPIEN 3 transcatheter pulmonary valve implantation (TPVI) system with Alterra adaptive prestent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results